CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Clinical program implementationbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04289363
NCT04289363N/ACompleted

Emergency Department Outcomes for Patients With Opioid Use Disorder

NYU Langone Health·observational·Posted Feb 28, 2020·Updated Jul 6, 2023

In Brief

An observational study evaluating Clinical program implementation for Opioid-use Disorder. Completed, enrolled 53 participants across 2 sites.

Detailed Summary

Using mixed methods and triangulating multiples sources of data collected over the course of the parent (CTN-0079 - NCT03544112) and the ancillary studies to evaluate the feasibility, acceptability, sustainability and impact of the emergency department (ED)-initiated Buprenorphine (BUP) clinical program and implementation facilitation strategy and identify factors influencing diffusion and effectiveness.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 28, 2020
Enrollment StartNov 25, 2020
Primary CompletionJan 28, 2022
Study CompletionFeb 18, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 6.3 years ago

Interventions

Clinical program implementationbehavioral

Using mixed methods and triangulating multiple sources of data collected over the course of parent and ancillary studies to evaluate the feasibility, acceptability, sustainability, and impact of the ED-initiated BUP clinical program and implementation facilitation strategy and identify factors influencing diffusion and effectiveness. Converging provider and patient perspectives and field notes with process measures and intervention outcomes, including proportions screened, treated, and engaged in treatment, will provide explanation to contextualize and better understand feasibility, acceptability, and factors associated with the rate with which the ED-initiated BUP innovation is adopted and how well it is sustained.